These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21404337)

  • 1. Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy.
    Kreis R; Wingeier K; Vermathen P; Giger E; Joncourt F; Zwygart K; Kaufmann F; Boesch C; Steinlin M
    NMR Biomed; 2011 Apr; 24(3):253-62. PubMed ID: 21404337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy.
    Wingeier K; Giger E; Strozzi S; Kreis R; Joncourt F; Conrad B; Gallati S; Steinlin M
    J Clin Neurosci; 2011 Jan; 18(1):90-5. PubMed ID: 21109441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy.
    Doorenweerd N; Straathof CS; Dumas EM; Spitali P; Ginjaar IB; Wokke BH; Schrans DG; van den Bergen JC; van Zwet EW; Webb A; van Buchem MA; Verschuuren JJ; Hendriksen JG; Niks EH; Kan HE
    Ann Neurol; 2014 Sep; 76(3):403-11. PubMed ID: 25043804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression.
    Daoud F; Angeard N; Demerre B; Martie I; Benyaou R; Leturcq F; Cossée M; Deburgrave N; Saillour Y; Tuffery S; Urtizberea A; Toutain A; Echenne B; Frischman M; Mayer M; Desguerre I; Estournet B; Réveillère C; Penisson-Besnier ; Cuisset JM; Kaplan JC; Héron D; Rivier F; Chelly J
    Hum Mol Genet; 2009 Oct; 18(20):3779-94. PubMed ID: 19602481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation.
    Pane M; Lombardo ME; Alfieri P; D'Amico A; Bianco F; Vasco G; Piccini G; Mallardi M; Romeo DM; Ricotti V; Ferlini A; Gualandi F; Vicari S; Bertini E; Berardinelli A; Mercuri E
    J Pediatr; 2012 Oct; 161(4):705-9.e1. PubMed ID: 22560791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmd(mdx) mouse.
    Vaillend C; Billard JM; Laroche S
    Neurobiol Dis; 2004 Oct; 17(1):10-20. PubMed ID: 15350961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism in muscle biopsies of Duchenne and Becker muscular dystrophy patients.
    Anand A; Prabhakar S; Kaul D
    Neurol India; 1999 Sep; 47(3):218-23. PubMed ID: 10514583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Evaluation of White Matter Abnormalities in Children with Duchenne Muscular Dystrophy Using DTI.
    Preethish-Kumar V; Shah A; Kumar M; Ingalhalikar M; Polavarapu K; Afsar M; Rajeswaran J; Vengalil S; Nashi S; Thomas PT; Sadasivan A; Warrier M; Nalini A; Saini J
    AJNR Am J Neuroradiol; 2020 Jul; 41(7):1271-1278. PubMed ID: 32616576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-occurrence of mutations in both dystrophin- and androgen-receptor genes is a novel cause of female Duchenne muscular dystrophy.
    Katayama Y; Tran VK; Hoan NT; Zhang Z; Goji K; Yagi M; Takeshima Y; Saiki K; Nhan NT; Matsuo M
    Hum Genet; 2006 Jun; 119(5):516-9. PubMed ID: 16528518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational cognitive modeling and validation of Dp140 induced alteration of working memory in Duchenne Muscular Dystrophy.
    Tyagi R; Aggarwal P; Mohanty M; Dutt V; Anand A
    Sci Rep; 2020 Jul; 10(1):11989. PubMed ID: 32686699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of dystrophin gene deletions in Malaysian patients with Duchenne muscular dystrophy.
    Marini M; Salmi AA; Watihayati MS; SMardziah MD; Zahri MK; Hoh BP; Ankathil R; Lai PS; Zilfalil BA
    Med J Malaysia; 2008 Mar; 63(1):31-4. PubMed ID: 18935728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
    den Dunnen JT; de Visser M; Bakker E
    Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain function in Duchenne muscular dystrophy.
    Anderson JL; Head SI; Rae C; Morley JW
    Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy.
    Banihani R; Smile S; Yoon G; Dupuis A; Mosleh M; Snider A; McAdam L
    J Child Neurol; 2015 Oct; 30(11):1472-82. PubMed ID: 25660133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening.
    Moizard MP; Toutain A; Fournier D; Berret F; Raynaud M; Billard C; Andres C; Moraine C
    Eur J Hum Genet; 2000 Jul; 8(7):552-6. PubMed ID: 10909857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?
    Kerr TP; Sewry CA; Robb SA; Roberts RG
    Hum Genet; 2001 Oct; 109(4):402-7. PubMed ID: 11702221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.
    Al-Jumah M; Majumdar R; Al-Rajeh S; Chaves-Carballo E; Salih MM; Awada A; Al-Shahwan S; Al-Uthaim S
    Saudi Med J; 2002 Dec; 23(12):1478-82. PubMed ID: 12518196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive dysfunction in the dystrophin-deficient mouse model of Duchenne muscular dystrophy: A reappraisal from sensory to executive processes.
    Chaussenot R; Edeline JM; Le Bec B; El Massioui N; Laroche S; Vaillend C
    Neurobiol Learn Mem; 2015 Oct; 124():111-22. PubMed ID: 26190833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.
    Deburgrave N; Daoud F; Llense S; Barbot JC; Récan D; Peccate C; Burghes AH; Béroud C; Garcia L; Kaplan JC; Chelly J; Leturcq F
    Hum Mutat; 2007 Feb; 28(2):183-95. PubMed ID: 17041906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.